Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: A new mechanical test for trochanteric region of rat femur

Osteoporosis International

Volumn 21, Issue 2, 2010, Pages 251-261

  Tezval, M ^a,b   Stuermer, E K ^a   Sehmisch, S ^a   Rack, T ^a   Stary, A ^a   Stebener, M ^a   Konietschke, F ^a   Stuermer, K M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Biomechanical test; Estradiol; Histomorphometric test; Osteoporosis; Parathyroid hormone; Trochanteric region

Indexed keywords

ESTROGEN; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; DIET; DRUG EFFECT; FEMALE; FEMUR; GREATER TROCHANTER; LESSER TROCHANTER; MORPHOMETRICS; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; RIGIDITY; SPRAGUE DAWLEY RAT; TRABECULAR BONE;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ELASTICITY; ESTRADIOL; FEMALE; FEMUR; HIP FRACTURES; OSTEOCALCIN; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; OVARIECTOMY; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL;

EID: 76549085385     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0941-y     Document Type: Article

References (24)

1. L Sliwinski J Folwarczna W Janiec G Grynkiewicz K Kuzyk 2005 Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro Pharmacol Rep 57 352 359 1:CAS:528:DC%2BD2MXhtVClurbK 15985718
2. H Burger 2003 Hormone replacement therapy in the post-Women's Health Initiative era. Report of a meeting held in Funchal, Madeira, February 24-25, 2003 Climacteric 6 Suppl 1 11 36 12945798
3. W Wuttke H Jarry S Westphalen V Christoffel D Seidlova-Wuttke 2002 Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol 83 133 147 10.1016/S0960-0760(02)00259-5 1:CAS:528:DC%2BD3sXitFahs7w%3D 12650710 (Pubitemid 37040650)
4. EF Eriksen 2002 Primary hyperparathyroidism: lessons from bone histomorphometry J Bone Miner Res 17 Suppl 2 N95 N97 12412784
5. T Matsumoto M Shiraki H Hagino H Iinuma T Nakamura 2006 Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study Osteoporos Int 17 1532 1538 10.1007/s00198-006-0159-1 1:CAS:528:DC%2BD28XpsFWls74%3D 16767525 (Pubitemid 44387488)
6. S Gonnelli G Martini C Caffarelli S Salvadori A Cadirni A Montagnani R Nuti 2006 Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis Osteoporos Int 17 1524 1531 10.1007/s00198-006-0157-3 1:CAS:528:DC%2BD28XpsFWlsrc%3D 16767526 (Pubitemid 44387487)
7. NC Partridge X Li L Qin 2006 Understanding parathyroid hormone action Ann N Y Acad Sci 1068 187 193 10.1196/annals.1346.024 1:CAS:528: DC%2BD28XntFentbs%3D 16831918 (Pubitemid 43824149)
8. C Ejersted TT Andreassen MH Nilsson H Oxlund 1994 Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats Eur J Endocrinol 130 201 207 10.1530/eje.0.1300201 1:CAS:528: DyaK2cXitlKksrw%3D 8130897
9. RM Neer CD Arnaud JR Zanchetta R Prince GA Gaich JY Reginster AB Hodsman EF Eriksen S Ish-Shalom HK Genant O Wang BH Mitlak 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434 1441 10.1056/NEJM200105103441904 1:CAS:528:DC%2BD3MXktVSgsbw%3D 11346808 (Pubitemid 32402100)
10. C Deal M Omizo EN Schwartz EF Eriksen P Cantor J Wang EV Glass SL Myers JH Krege 2005 Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial J Bone Miner Res 20 1905 1911 10.1359/JBMR.050714 1:CAS:528:DC%2BD2MXht1amt7nP 16234962 (Pubitemid 41532775)
11. A Ishihara T Sasaki K Debari R Furuya T Kawawa NS Ramamurthy LM Golub 1999 Effects of ovariectomy on bone morphology in maxillae of mature rats J Electron Microsc (Tokyo) 48 465 469 1:CAS:528:DyaK1MXmtVSmurw%3D
12. DD Thompson HA Simmons CM Pirie HZ Ke 1995 FDA Guidelines and animal models for osteoporosis Bone 17 125S 133S 10.1016/8756-3282(95)97353-H 1:STN:280:DyaK287hvFWrsQ%3D%3D 8579908
13. TJ Wronski PL Lowry CC Walsh LA Ignaszewski 1985 Skeletal alterations in ovariectomized rats Calcif Tissue Int 37 324 328 10.1007/BF02554882 1:STN:280:DyaL2M3lsVSmuw%3D%3D 3926284 (Pubitemid 15034552)
14. G Zhang L Qin Y Shi K Leung 2005 A comparative study between axial compression and lateral fall configuration tested in a rat proximal femur model Clin Biomech (Bristol, Avon) 20 729 735 10.1016/j.clinbiomech.2005.03.016 (Pubitemid 40917243)
15. EK Sturmer D Seidlova-Wuttke S Sehmisch T Rack J Wille KH Frosch W Wuttke KM Sturmer 2006 Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene J Bone Miner Res 21 89 96 10.1359/JBMR.050913 16355277 (Pubitemid 43023230)
16. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 595 610 1:STN:280:DyaL1czjvVemsQ%3D%3D 3455637
17. CM Bagi D Wilkie K Georgelos D Williams D Bertolini 1997 Morphological and structural characteristics of the proximal femur in human and rat Bone 21 261 267 10.1016/S8756-3282(97)00121-X 1:STN:280:DyaK2svit1Sjtg%3D%3D 9276091 (Pubitemid 27404083)
18. L Mosekilde CC Danielsen J Gasser 1994 The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats Endocrinology 134 2126 2134 10.1210/en.134.5.2126 1:CAS:528:DyaK2cXivFSmsrk%3D 8156913 (Pubitemid 24142953)
19. CM Bagi P Ammann R Rizzoli SC Miller 1997 Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats Calcif Tissue Int 61 336 344 10.1007/s002239900344 1:CAS:528: DyaK2sXmsFCltbk%3D 9312205 (Pubitemid 27430120)
20. M Mukherjee AS Das D Das S Mukherjee S Mitra C Mitra 2006 Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17beta-estradiol Phytother Res 20 21 27 10.1002/ptr.1795 1:CAS:528:DC%2BD28XhsFGrsbs%3D 16397916 (Pubitemid 43171583)
21. V Shen R Birchman R Xu M Otter D Wu R Lindsay DW Dempster 1995 Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats J Clin Invest 96 2331 2338 10.1172/JCI118289 1:CAS:528:DyaK28XltF2iuw%3D%3D 7593620
22. H Oxlund G Ortoft JS Thomsen CC Danielsen C Ejersted TT Andreassen 2006 The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment Bone 39 244 252 10.1016/j.bone.2006.01.142 1:CAS:528: DC%2BD28Xls1ejt7o%3D 16503210 (Pubitemid 43851361)
23. P Vestergaard NR Jorgensen L Mosekilde P Schwarz 2007 Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk-a meta-analysis Osteoporos Int 18 45 57 10.1007/s00198-006-0204-0 1:CAS:528:DC%2BD28Xht1OhtrfO 16951908 (Pubitemid 44885495)
24. DW Dempster F Cosman ES Kurland H Zhou J Nieves L Woelfert E Shane K Plavetic R Muller J Bilezikian R Lindsay 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study J Bone Miner Res 16 1846 1853 10.1359/jbmr.2001.16.10.1846 1:CAS:528:DC%2BD3MXnsVKqtLw%3D 11585349